SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 147.37 |
Enterprise Value ($M) | n/a |
Book Value ($M) | 27.70 |
Book Value / Share | 2.20 |
Price / Book | n/a |
NCAV ($M) | -48.98 |
NCAV / Share | -3.89 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.61 |
Return on Assets (ROA) | -0.39 |
Return on Equity (ROE) | -0.87 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.26 |
Current Ratio | 1.64 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 75.81 |
Assets | 152.49 |
Liabilities | 124.79 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 39.12 |
Operating Income | -33.15 |
Net Income | -41.97 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -35.53 |
Cash from Investing | -0.06 |
Cash from Financing | 46.08 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
SNNC – Sibannac, Inc. | SNPHF – Santen Pharmaceutical Co., Ltd. |
SNYNF – Sanofi | SPRB – Spruce Biosciences, Inc. |
SQZB – SQZ Biotechnologies Company |
Financial data and stock pages provided by
Fintel.io